Diabetes increases brain damage caused by severe hypoglycemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 1, 2009, Pages

  Bree, Adam J ^a   Puente, Erwin C ^a   Daphna Iken, Dorit ^a   Fisher, Simon J ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluoro Jade; Insulin; Seizure; Streptozotocin

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CELL DAMAGE; CELL DEATH; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTATE GYRUS; DIABETES MELLITUS; DISEASE SEVERITY; GLUCOSE CLAMP TECHNIQUE; HIPPOCAMPUS; HISTOLOGY; HYPERINSULINEMIA; HYPOGLYCEMIA; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; SEIZURE; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN DISEASES; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; HYPOGLYCEMIA; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 67650071005     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.91041.2008     Document Type: Article

References (55)

1. Alkire MT, Pomfrett CJ, Haier RJ, Gianzero MV, Chan CM, Jacobsen BP, Fallon JH. Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology 90: 701-709, 1999.
2. Auer RN. Hypoglycemic brain damage. Metab Brain Dis 19: 169-175, 2004.
3. Auer RN, Hugh J, Cosgrove E, Curry B. Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8: 63-68, 1989.
4. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 22: 1273-1277, 1999.
5. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34: 2208-2214, 2003.
6. Bean L, Zheng H, Patel KP, Monaghan DT. Regional variations in NMDA receptor downregulation in streptozotocin-diabetic rat brain. Brain Res 1115: 217-222, 2006.
7. Bjorgaas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 86: 148-153, 1997.
8. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333: 1726-1731, 1995.
9. Butcher SP, Sandberg M, Hagberg H, Hamberger A. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J Neurochem 48: 722-728, 1987.
10. Canal CE, McNay EC, Gold PE. Increases in extracellular fluid glucose levels in the rat hippocampus following an anesthetic dose of pentobarbital or ketamine-xylazine: an in vivo microdialysis study. Physiol Behav 84: 245-250, 2005.
11. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32: 2426-2432, 2001.
12. Chan O, Inouye K, Akirav EM, Park E, Riddell MC, Matthews SG, Vranic M. Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia. Am J Physiol Regul Integr Comp Physiol 289: R235-R246, 2005.
13. Chan O, Inouye K, Vranic M, Matthews SG. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143: 1761-1768, 2002.
14. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 10: 617-621, 1987.
15. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26: 1902-1912, 2003.
16. Golden MP, Ingersoll GM, Brack CJ, Russell BA, Wright JC, Huberty TJ. Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 12: 89-93, 1989.
17. Gutniak M, Blomqvist G, Widén L, Stone-Elander S, Hamberger B, Grill V. D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol Endocrinol Metab 258: E805-E812, 1990.
18. Hershey T, Lillie R, Sadler M, White NH. Severe hypoglycemia and long-term spatial memory in children with type 1 diabetes mellitus: a retrospective study. J Int Neuropsychol Soc 9: 740-750, 2003.
19. Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY. The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res 1052: 1-9, 2005.
20. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356: 1842-1852, 2007.
21. Jeong YB, Kim JS, Jeong SM, Park JW, Choi IC. Comparison of the effects of sevoflurane and propofol anaesthesia on regional cerebral glucose metabolism in humans using positron emission tomography. J Int Med Res 34: 374-384, 2006.
22. Johnson SA, Young C, Olney JW. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 20: 21-28, 2008.
23. Kaufman FR, Epport K, Engilman R, Halvorson M. Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications 13: 31-38, 1999.
24. Kondo F, Asanuma M, Miyazaki I, Kondo Y, Tanaka K, Makino H, Ogawa N. Progressive cortical atrophy after forebrain ischemia in diabetic rats. Neurosci Res 39: 339-346, 2001.
25. Kramer L, Fasching P, Madl C, Schneider B, Damjancic P, Waldhausl W, Irsigler K, Grimm G. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes 47: 1909-1914, 1998.
26. Lin B, Ginsberg MD, Busto R. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations. Acta Neuropathol 96: 610-620, 1998.
27. Malone JI, Hanna SK, Saporta S. Hyperglycemic brain injury in the rat. Brain Res 1076: 9-15, 2006.
28. Martinez-Tellez R, Gomez-Villalobos MJ, Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048: 108-115, 2005.
29. Mielke JG, Taghibiglou C, Wang YT. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience 143: 165-173, 2006.
30. Moreira T, Cebers G, Pickering C, Ostenson CG, Efendic S, Liljequist S. Diabetic Goto-Kakizaki rats display pronounced hyperglycemia and longer-lasting cognitive impairments following ischemia induced by cortical compression. Neuroscience 144: 1169-1185, 2007.
31. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55: 326-333, 2006.
32. Nakao Y, Itoh Y, Kuang TY, Cook M, Jehle J, Sokoloff L. Effects of anesthesia on functional activation of cerebral blood flow and metabolism. Proc Natl Acad Sci USA 98: 7593-7598, 2001.
33. Nellgård B, Wieloch T. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 92: 259-266, 1992.
34. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24: 1541-1546, 2001.
35. Northam EA, Anderson PJ, Werther GA, Warne GL, Andrewes D. Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 22: 1438-1444, 1999.
36. Pelligrino DA, LaManna JC, Duckrow RB, Bryan RM Jr, Harik SI. Hyperglycemia and blood-brain barrier glucose transport. J Cereb Blood Flow Metab 12: 887-899, 1992.
37. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30: 2331-2337, 2007.
38. Rizk NN, Rafols JA, Dunbar JC. Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res 1096: 204-212, 2006.
39. Rovet JF, Ehrlich RM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr 134: 503-506, 1999.
40. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035: 24-31, 2005.
41. Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45: 108-114, 2002.
42. Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72: 238-247, 1999.
43. Strudwick SK, Carne C, Gardiner J, Foster JK, Davis EA, Jones TW. Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia. J Pediatr 147: 680-685, 2005.
44. Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 23: 10681-10690, 2003.
45. Suh SW, Aoyama K, Matsumori Y, Liu J, Swanson RA. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54: 1452-1458, 2005.
46. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117: 910-918, 2007.
47. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 55: 1280-1286, 2007.
48. Telushkin PK, Nozdrachev AD, Potapov PP, Medvedeva NB, Stel'makh AY. Glycolysis and oxidation enzyme activity in rat brain during insulin-induced hypoglycemia against the background of alloxan-induced diabetes mellitus. Bull Exp Biol Med 140: 695-697, 2005.
49. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23: 1467-1471, 2000.
50. Tkacs NC, Dunn-Meynell AA, Levin BE. Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes 49: 820-826, 2000.
51. Tkacs NC, Pan Y, Raghupathi R, Dunn-Meynell AA, Levin BE. Cortical Fluoro-Jade staining and blunted adrenomedullary response to hypoglycemia after noncoma hypoglycemia in rats. J Cereb Blood Flow Metab 25: 1645-1655, 2005.
52. Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 797: 1-11, 1998.
53. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metab 11: 1006-1014, 1991.
54. Wieloch T, Engelsen B, Westerberg E, Auer R. Lesions of the glutamatergic cortico-striatal projections in the rat ameliorate hypoglycemic brain damage in the striatum. Neurosci Lett 58: 25-30, 1985.
55. Wysocki T, Harris MA, Mauras N, Fox L, Taylor A, Jackson SC, White NH. Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 26: 1100-1105, 2003.